Newleos Therapeutics Secures $93.5 Million Series A Financing for Clinical-Stage Pipeline

Newleos Therapeutics, Inc. secures funding to support clinical-stage pipeline targeting prevalent neuropsychiatric conditions.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here